Benign gastric polyps: Morphological and functional origin

Digestive Diseases and Sciences

Volumn 48, Issue 7, 2003, Pages 1292-1297

  Borch, Kurt ^a   Skarsgård, John ^b   Franzén, Lennart ^b   Mårdh, Sven ^b   Rehfeld, Jens F ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Gastrin; Gastritis; H+,K+ ATPase antibodies; Helicobacter pylori; Morphology; Pepsinogen I; Polyps; Stomach

Indexed keywords

ANTIBODY; GASTRIN; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE ANTIBODY; PEPSINOGEN; UNCLASSIFIED DRUG;

ADENOMA; ANTIBODY TITER; ARTICLE; ATROPHIC GASTRITIS; CARCINOID; CLINICAL FEATURE; DISEASE CLASSIFICATION; GASTRITIS; HAMARTOMA; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; HYPERPLASIA; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; SCORING SYSTEM; SEROLOGY; STOMACH BIOPSY; STOMACH POLYP;

ADENOMATOUS POLYPS; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; FEMALE; GASTRINS; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HUMANS; MALE; MIDDLE AGED; NA(+)-K(+)-EXCHANGING ATPASE; PEPSINOGEN A; POLYPS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 0038049825     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024150924457     Document Type: Article

References (50)

1. Rosen S, Hoak D: Intramucosal carcinoma developing in a hyperplastic gastric polyp. Gastrointest Endosec 39:830-832, 1993
2. Stolte M, Sticht T, Eidt S, Ebert D, Finkenzeller G: Frequency, location and age and sex distribution of various types of gastric polyps. Endoscopy 26:659-665, 1994
3. Stolte M: Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy 27:32-37, 1995
4. WHO Classification of Tumours. Pathology and Genetics: Tumours of the Digestive System. IARC Press, Lyon, France, 2000
5. Ming S, Goldman H: Gastric polyps. A histogenetic classification and its relation to carcinoma. Cancer 18:721-726, 1965
6. Elster K: Histologic classification of gastric polyps. Curr Top Pathol 63:77-93, 1976
7. Daibo M, Itahashi M, Hirota T: Malignant transformation of gastric hyperplastic polyps. Am J Gastroenterol 82:1016-1025, 1987
8. Järvinen HJ: Other gastrointestinal polyps. World J Surg 15:50-56, 1991
9. Cristallini E, Ascani S, Bolis G. Association between histologic type of polyp and carcinoma in the stomach. Gastrointest Endosc 38:481-484, 1992
10. Hizawa K, Fuchigami T, Iida M, Aoyagi K, Iwashita A, Daimaru Y, Fujishima M: Possible neoplastic transformation within gastric hyperplastic polyp. Surg Endosc 9:714-718, 1995
11. Orlowska J, Jarosz D, Pachlewski J, Butruk E: Malignant transformation of benign epithelial gastric polyps. Am J Gastroenterol 90:2152-2159, 1995
12. Papa A, Cammarota G, Tursi A, Montalto M, Cuoco L, Certo M, et al: Histologic types and surveillance of gastric polyps: a seven year clinico-pathological study. Hepato-Gastroenterol 45:579-582, 1998
13. Rattan J, Arber N, Tiomny E, Moshkowitz M, Chapsky Y, Baratz M, et al: Gastric polypoid lesions - an eight year study. Hepatogastroenterol 40:107-109, 1993
14. Haruma K, Sumii K, Yoshihara M, Watanabe C, Kajiyama G: Gastric mucosa in female patients with fundic glandular polyps. J Clin Gastroenterol 13:565-569, 1991
15. Haruma K, Yoshihara M, Sumii K, Tari A, Watanabe C, Kodoi A, et al: Gastric acid secretion, serum pepsinogen I, and serum gastrin in Japanese with gastric hyperplastic polyps or polypoid-type early gastric carcinoma. Scand J Gastroenterol 28:633-637, 1993
16. Laxen F, Kekki M, Sipponen P, Siurala M: The gastric mucosa in stomachs with polyps: morphologic and dynamic evaluation. Scand J Gastroenterol 18:503-511, 1983
17. Nakano H, Persson B, Slezak P: Study of the gastric mucosal background in patients with gastric polyps. Gastrointest Endosc 36:39-42, 1990
18. Sakai N, Tatsuta M, Hirasawa R, Iishi H, Baba M, Yokota Y, et al: Low prevalence of Helicobacter pylori infection in patients with hamartomatous fundic polyps. Dig Dis Sci 43:766-772, 1998
19. Borch K, Renvall H, Liedberg G: Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology 88:638-648, 1985
20. Carneiro F, David L, Seruca R, Castedo S, Nesland JM, Sobrinho-Simoes M: Hyperplastic polyposis and diffuse carcinoma of the stomach. A study of a family. Cancer 72:323-329, 1993
21. Orlowska J, Pietrow D. Multifocal gastric carcinoma arising from hyperplastic and adenomatous polyps. Am J Gastroenterol 85:1629-1634, 1990
22. Harju E: Gastric polyposis and malignancy. Br J Surg 73:532-533, 1986
23. Dickey W, Kenny BD, McConnell JB: Prevalence of fundic gland polyps in a western European population. J Clin Gastroenterol 23:73-75, 1996
24. Iida M, Yao T, Itoh H, Watanabe H, Kohrogi N, Shigematsu A, et al: Natural history of fundic gland polyposis in patients with familial adenomatosis coli/Gardner's syndrome. Gastroenterology 89:1021-1025, 1985
25. Kinoshita Y, Tojo M, Yano T, Kitajima N, Itoh T, Nishiyama K, et al: Incidence of fundic gland polyps in patients without familial adenomatous polyposis. Gastointest Endosc 39:161-163, 1993
26. Marcial MA, Villafana M, Hernandez-Denton J, Colon-Pagan JR: Fundic gland polyps: prevalence and clinicopathologic features. Am J Gastroenterol 88:1711-1713, 1993
27. El-Zimaity HMT, Jackson FW, Graham DY: Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol 92:1858-1860, 1997
28. Ginsberg GG, Al-Kawas FH, Fleischer DE, Reilly HF, Benjamin SB: Gastric polyps: relationship of size and histology to cancer risk. Am J gastroenterol 91:714-717, 1996
29. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, et al: Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 93:1090-1096, 1998
30. King RM, van Heerden JA, Weiland LH: The management of gastric polyps. Surg Gynecol Obstet 155:846-848, 1982
31. Borch K, Renvall H, Liedberg G, Andersen BN: Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand J Gastroenterol 21:357-363, 1986
32. Hallissey MT, Dunn JA, Fielding JWL: Evaluation of pepsinogen I and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions. Scand J Gastroenterol 29:1129-1134, 1994
33. Westerveld BD, Pals G, Lamers CB, Defize J, Pronk JC, Frants RR, Meuwissen SGM, et al: Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels; and serum gastrin levels. Cancer 59:952-958, 1987
34. Toh BH, van Driel IR, Gleeson PA: Pernicious anemia. N Engl J Med 13:1441-1448, 1997
35. Varis O, Laxen F, Valle J: Helicobacter pylori infection and fasting serum gastrin levels in a series of endoscopically diagnosed gastric polyps. APMIS 102:759-764,
36. Borch K, Kullman E, Hallhagen S, Ledin T, Ihse I: Increased incidence of pancreatic neopiasia in pernicious anemia. World J Surg 12:866-870, 1988
37. Borch K: Atrophic gastritis and carcinoid tumours. Ann Med 21:291-297, 1989
38. Sipponen P, Kekki M, Haapakoski J, Ihamäki T, Siurala M: Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 35:173-177, 1985
39. Veereman Wauters G, Ferrell L, Ostroff JW, Heyman MB: Hyperplastic gastric polyps associated with persistent Helicobacter pylori infection and active gastritis. Am J Gastroenterol 85:1395-1397, 1990
40. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 20:1161-1181, 1996
41. Ma JY, Borch K, Sjöstrand SE, Janzon L, Mårdh S: Positive correlation between H,K-adenosine triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. Scand J Gastroenterol 29:961-965, 1994
42. Rehfeld JF, Stadil F, Rubin B: Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest 30:221-232, 1972
43. Rehfeld JF: Sequence-specific radioimmunoassays for gastrin, cholecystokinin and somatostatin. Biomed Res 1:73-78,
44. Borch K, J nsson K-, Petersson F, Rede n S, M rdh S, Franz n LE: Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample: Relations to symptomatology and life style. Dig Dis Sci 45:1322-1329, 2000
45. Samloff IM, Varis K, Ihamäki T, Siurala M, Rotter JI: Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology - a study in relatives of patients with pernicious anemia. Gastroenterol 83:204-209, 1982
46. Borch K, Axelsson CK, Halgreen H, Damkjaer-Nielsen MD, Ledin T, Szesci PB: The ratio of pepsinogen I to pepsinogen C: A sensitive test for atrophic gastritis. Scand J Gastroenterol 24:870-876, 1989
47. Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M: Long-term course and sonsequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 31:546-550, 1996
48. Howden CW: Clinical expression of Helicobacter pylori infection. Am J Med 100:27S-34S, 1996
49. McFarlane GA, Munro A: Helicobacter pylori and gastric cancer. Br J Surg 84:1190-1199, 1997
50. Zwick A, Munir M, Ryan CK, Gian J, Burt RW, Leppert M, et al: Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology 113:659-663, 1997